Brief: Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch
20/10/2025 13:44
Oct 20 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY SIGNS U.S. DISTRIBUTION AGREEMENT WITH MCKESSON TO SUPPORT LYMPHIR™ COMMERCIAL LAUNCH CITIUS ONCOLOGY INC - LYMPHIR COMMERCIAL LAUNCH PLANNED FOR Q4 2025 Source text: ID:nPn15xXh8a Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on McKesson
See all newsMedia: McKesson's medical unit prices $2.25 billion leveraged loan ahead of IPO- Bloomberg News
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson beats Q4 profit estimates, maintains long-term profit growth forecast
Brief: McKesson Q4 Adjusted EPS USD 11.69 Vs. IBES Estimate USD 11.6